@NEJMres360 Journal Club with Tecnológico de Monterrey-Tecsalud Internal Medicine Residency Program on Therapeutic Anticoagulation in Critically Ill and Non-Critically Ill Patients with Covid-19

Q&A ends
Post Your Question

Ask a Question

·
Please type something here. This field is required.
·
Upload Image
Remove

Post Your Question
Authors
    • Critical Care Medicine
    • Hematology
    • Internal Medicine

    Dr. Zarychanski is a Hematologist, Critical Care physician, and Clinician-Scientist at the University of Manitoba and CancerCare Manitoba. His research focuses on the hematologic aspects of critical illness where he leads several national and international randomized trials in the fields of sepsis and transfusion medicine. Dr. Zarychanski is the chair of the COVID-19 clinical trials team in Manitoba and serves as the chair for 2 international trials evaluating anticoagulation strategies in COVID-19 and sepsis

    • Intensive Care
    • Assistant Professor of Medicine at University of Toronto

    Dr. Goligher is Assistant Professor of Medicine at the University of Toronto and a Clinician-Scientist at Toronto General Hospital Research Institute. He practices critical care medicine at University Health Network, Toronto, Canada.

    • Critical Care Medicine
    • Associate Chief of Academic Affairs & Director of Critical Care Research in the Division of Critical Care Medicine at Montefiore Medical Center

    Dr. Gong is the Chief of Division of Critical Care Medicine, Chief of Division of Pulmonary Medicine and Director of Critical Care Research at Montefiore Medical Center and Professor in Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master’s degree in Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine. She joined the Einstein/Montefiore faculty in July 2009. Dr. Gong is recognized nationally and internationally for her expertise in critical care research. A model clinician-researcher, her scientific projects influence her clinical care, and her patients influence her research. Her overall research focus has been on the prediction and prevention of acute critical illness and their complications. Continuously funded by the NIH for over 15 years for her research, her current research range from acute respiratory distress syndrome (ARDS) to prevention of delirium, treatment of severe influenza, big data and predictive analytics to identify patients at risk for respiratory failure or clinical deterioration, and effective clinical decision support. Most recently, she have developed and conducted clinical trials in COVID-19 as part of the NHLBI PETAL Network and the ACTIV4A Platform Trials.

  • Dr. Berry is a Statistical Scientist at Berry Consultants. She earned her PhD in Statistical Science from Duke University. Her work at Berry Consultants is primarily focused on the design and analysis of innovative adaptive and Bayesian clinical trials. 

    • Surgical Critical Care
    • Roberta G. Simmons Associate Professor of Surgery at UPMC

    Matthew D. Neal, MD FACS is the Roberta G. Simmons Associate Professor of Surgery and Associate Professor of Critical Care Medicine and Clinical and Translational Science at the University of Pittsburgh, Pittsburgh, PA, USA.  He is an attending trauma surgeon and surgical intensivist at UPMC. He serves as the Director of the Pittsburgh Trauma Research Center, which is a coordinating center to leverage collaboration and resource in trauma care. Dr. Neal also serves as one of the three directors of the Coordinating Center and the co-chair of the in-patient clinical trial committee for the NIH and Operation Warp Speed funded Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 (ACTIV-4) pandemic response. His lab is funded by the National Institutes of Health, Department of Defense, and private industry.  Dr. Neal is the principal investigator or co-investigator on a number of ongoing clinical trials in trauma and surgical care. 

Powered by Medstro